Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > REGULATORY
REGULATORY
- Payer Rep Insists CEA-Based Price Hike “Not an Option,” MHLW Wants “Grounds” for That Argument: Chuikyo
October 26, 2017
- Consumer Representative on MHLW Advisory Panel Resigns after Taking Regular Payments from Megmilk Snow Brand
October 26, 2017
- Patient Dies due to Mix-Up of Lixiana, Rifxima; PMDA, Companies Issue Warning Statement
October 26, 2017
- Cabinet Approves 5-Year Plan to Promote Anticancer Measures
October 26, 2017
- Sanofi’s Dupilumab, Chugai’s PD-L1 Inhibitor and More Up for MHLW Panel Review on Nov. 6
October 25, 2017
- Conditional Early Approval System Gets Underway: MHLW
October 23, 2017
- LDP Healthcare Big Names Handily Nab Seats in Snap Election
October 23, 2017
- MHLW to Discuss Drug Wholesalers’ License Requirements Related to Their “Operational Systems”
October 23, 2017
- MHLW to Discuss Redefinition of Drug “Seals”, Will Revise List of Examples of Seals Included in 1961 Notification
October 23, 2017
- Japan Introduction of GDP Likely to Begin with Guideline that Calls on Companies to Make “Good Faith Effort”: MHLW Study Group
October 23, 2017
- MHLW Advisory Panel to Discuss Pediatric Dosages for Nexium on Nov. 2
October 20, 2017
- Restrictions on Continuous Psychotropic Use Up for Chuikyo Discussions
October 19, 2017
- Price Maintenance Premium, Z2 Reduction Rates under Attack by CEFP Working Group
October 19, 2017
- Chuikyo Discussing Measures to Promote Proper Use of Clozaril for Patients with Treatment-Resistant Schizophrenia
October 19, 2017
- National Database Initiative for Regenerative Medicine Goes Live; Use for Review, Development Eyed
October 18, 2017
- Label Revisions Ordered for 5 APIs, Hitting Slew of Amoxicillin/Chlorhexidine Products
October 18, 2017
- Post-Transplant Patients Added to Careful Use List for Keytruda Label/Guidelines
October 18, 2017
- MHLW to Issue Notification on Revised Format for Package Inserts of Vaccines in Early December
October 18, 2017
- Cabinet Secretariat to Discuss Details of Research on Genome Editing to Be Supported by AMED
October 16, 2017
- MHLW to Purchase Enough Avigan for 44,000 More People, Agreement Expected Nov. 1
October 13, 2017
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…